205 related articles for article (PubMed ID: 16802779)
1. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
Yoshihara S; Yamada Y; Abe T; Arisaka O
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
[No Abstract] [Full Text] [Related]
2. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
Fujimori K; Suzuki E; Gejyo F
Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
[No Abstract] [Full Text] [Related]
3. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Kobayashi Y; Yasuba H; Kudou M; Kita H
J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
[TBL] [Abstract][Full Text] [Related]
5. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
6. [Long-acting beta 2-stimulants].
Tamura G
Nihon Rinsho; 2001 Oct; 59(10):1973-8. PubMed ID: 11676141
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
[TBL] [Abstract][Full Text] [Related]
8. Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma.
Rühle KH; Dorow P; Schmitz-Schumann H
Lung; 1990; 168 Suppl():192-3. PubMed ID: 1974676
[No Abstract] [Full Text] [Related]
9. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
[TBL] [Abstract][Full Text] [Related]
10. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
[TBL] [Abstract][Full Text] [Related]
11. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
[TBL] [Abstract][Full Text] [Related]
12. Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
Akamatsu K; Yamagata T; Takahashi T; Miura K; Maeda S; Yamagata Y; Ichikawa T; Yanagisawa S; Ueshima K; Hirano T; Nakanishi M; Matsunaga K; Minakata Y; Ichinose M
Pulm Pharmacol Ther; 2007; 20(6):701-7. PubMed ID: 17049894
[TBL] [Abstract][Full Text] [Related]
13. Easier breathing?
Cydulka RK
Ann Emerg Med; 2000 Sep; 36(3):236-8. PubMed ID: 10969227
[No Abstract] [Full Text] [Related]
14. On-demand relief treatment for asthma.
Joseph J; Badrinath P
Lancet; 2001 Jun; 357(9271):1882-3. PubMed ID: 11417575
[No Abstract] [Full Text] [Related]
15. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
Burioka N; Miyata M; Endo M; Fukuoka Y; Suyama H; Nakazaki H; Igawa K; Shimizu E
Chronobiol Int; 2005; 22(2):383-90. PubMed ID: 16021849
[TBL] [Abstract][Full Text] [Related]
17. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
18. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
19. Inhaled beta 2-agonists and corticosteroids in the treatment of children with acute asthma attack.
Volovitz B; Nussinovitch M
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):891-2. PubMed ID: 12455174
[No Abstract] [Full Text] [Related]
20. Asthma guidelines.
Jack D
Thorax; 1997 Jul; 52(7):665; author reply 665-6. PubMed ID: 9246148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
